Literature DB >> 26404775

Trichosporon asahii Infection in a Patient with Metastatic Prostate Cancer as an Example of an Emerging Fungal Pathogen.

Kyle Magee1, D Jane Hata2, Diana Meza2.   

Abstract

CLINICAL HISTORY PATIENT: 59-year-old white man. CHIEF COMPLAINT: Nausea, constant urge to urinate, and intermittent lower back pain that wraps around his right iliac crest and down his right anterior thigh to the level of his right knee. HISTORY OF PRESENT ILLNESS: The patient sought radiation oncology consultation for his metastatic prostate cancer. He has had nephrostomy tubes and ureteral stents implanted to help with his bilateral uropathic manifestations. Two days earlier, his ureteral stent was removed and sent for culture during the replacement of his malfunctioning nephrostomy tubes; Trichosporon asahii had been cultured from the stent. PREVIOUS MEDICAL HISTORY: Castration-resistant prostate cancer with bone metastasis, left upper abdominal shingles, recurrent urinary tract infections (UTIs), chronic anemia due to chemotherapy, and obstructive bilateral uropathy. FAMILY HISTORY: Mother had breast cancer and father had lung cancer and heart disease. PHYSICAL EXAMINATION
FINDINGS: The patient was alert and oriented. There was a small, soft, compressible nodule, or cyst, in the posterior supraclavicular region. His lungs were clear, and his pulse had a regular rate and rhythm. PRINCIPLE LABORATORY
FINDINGS: Table 1. Copyright© by the American Society for Clinical Pathology (ASCP).

Entities:  

Keywords:  Trichosporon asahii; fungus; metastatic prostate cancer; microbiology; opportunistic pathogen; yeast

Mesh:

Year:  2015        PMID: 26404775     DOI: 10.1309/LMDDUCADJ31LE0ML

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  1 in total

1.  Prognostic correlations with the microbiome of breast cancer subtypes.

Authors:  Sagarika Banerjee; Zhi Wei; Tian Tian; Dipayan Bose; Natalie N C Shih; Michael D Feldman; Thaer Khoury; Angela De Michele; Erle S Robertson
Journal:  Cell Death Dis       Date:  2021-09-04       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.